13F filer · CIK 1750122
Aquilo Capital Management, LLC
SAN FRANCISCO, CA · filing since Q2 2018 · last filing Nov 14, 2018
Reported value
$238.9M
+$117.7M vs prior
Positions
12
New / sold out
1 / 3
Added / reduced
7 / 3
Turnover
8.5%
buys $78.3M · sells $15.3M
Top-10 weight
98.4%
Biggest buys vs Q2 2018
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | SPDR SERIES TRUSTPUT | +500,000 | +83.3% | +$47.9M |
| Added | SYNLOGIC INC | +691,240 | +225.3% | +$9.8M |
| New | XENON PHARMACEUTICALS INC | +592,802 | – | +$7.8M |
| Added | FATE THERAPEUTICS INC | +404,367 | +69.7% | +$6.6M |
| Added | SPERO THERAPEUTICS INC | +383,000 | +91.9% | +$4.0M |
| Added | MERUS N V | +44,799 | +3.6% | +$884.3K |
| Added | ADURO BIOTECH INC | +97,383 | +4.8% | +$715.8K |
| Added | CYTOMX THERAPEUTICS INC | +25,000 | +3.8% | +$462.5K |
Biggest sells vs Q2 2018
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | AUTOLUS THERAPEUTICS PLC | -150,000 | -100.0% | $-4.0M |
| Reduced | GALAPAGOS NV | -34,730 | -52.6% | $-3.9M |
| Sold out | CELLECTIS S A | -118,873 | -100.0% | $-3.4M |
| Reduced | LOXO ONCOLOGY INC | -17,500 | -13.8% | $-3.0M |
| Sold out | FIVE PRIME THERAPEUTICS INC | -64,881 | -100.0% | $-1.0M |
| Reduced | MORPHOSYS AG | -913 | -9.1% | $-24.4K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2018
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SPDR SERIES TRUSTPUTS&P BIOTECH | 1,100,000 | $105.5M | 44.14% |
| 2 | MERUS N VCOM | 1,295,713 | $25.6M | 10.70% |
| 3 | LOXO ONCOLOGY INCCOM | 109,312 | $18.7M | 7.82% |
| 4 | FATE THERAPEUTICS INCCOM | 984,596 | $16.0M | 6.71% |
| 5 | ADURO BIOTECH INCCOM | 2,105,282 | $15.5M | 6.48% |
| 6 | SYNLOGIC INCCOM | 998,034 | $14.2M | 5.94% |
| 7 | CYTOMX THERAPEUTICS INCCOM | 674,763 | $12.5M | 5.22% |
| 8 | PIERIS PHARMACEUTICALS INCCOM | 1,975,098 | $11.1M | 4.63% |
| 9 | SPERO THERAPEUTICS INCCOM | 799,691 | $8.4M | 3.52% |
| 10 | XENON PHARMACEUTICALS INCCOM | 592,802 | $7.8M | 3.27% |
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.